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ABBREVIATIONS
1.ACHD Acyanotic congenital heart disease
2.AGA Appropriate for gestational age
3.ASD Atrial septal defect
4.CCHD Congenital cyanotic heart disease
5.CHD Congenital heart disease
6.CNS Central nervous system
7.CVS Cardiovascular system
8.CXR Chest x ray
9.GDM Gestational diabetes mellitus
10.IDM Infant of diabetic mother
11.L/S RATIO Lecithin spingomyelin ratio
12.LGA Large for gestational age
13.NICU Neonatal intensive care unit
14.OGTT Oral glucose tolerance test
15.PDA Patent ductus arteriosus
16.PFO Patent foramen ovale
17.SGA Small for gestational age
18.TA Tricuspid atresia
19.TGA Transposition of great  vessels
20.VSD Ventricular septal defect
11.INTRODUCTION
Diabetes mellitus is one of the most common medical problems
worldwide. The world health organization has predicted that the prevalence
of diabetes will increase by 35% by 2025.1,2 Women of Asian origin have
more risk of developing diabetes. Now, gestational diabetes mellitus is
increasing and amounts to 17% in Asian women but only 4% of American
& European women.3,4
In southern India, the prevalence of GDM was 17% in urban
women, 13.8% in semi urban and 9.8% in rural .4,5 Overt Diabetes and
GDM where associated with high perinatal  mortality and morbidity, to
add to that there was increased incidence of still birth and birth defects.
When compared to babies of non-diabetic women, IDM babies showed
more incidence of neonatal complications.6 By reviewing recent data was
shown that OHA were effective in control of diabetes during pregnancy,
with no teratogenic effect.7
Birth defects were common in the order of cardiac and neural tube
defects. In the offspring’s of  diabetic mother, the incidence of cardiac
anomalies was 3 to 6% which is 5 times higher than non-diabetic
pregnancy and most of the time it included complex congenital heart
disease.8,9More frequently reported anomalies were conotruncal  such as
truncus arteriosus ,tricuspid atresia , TGA. The incidence of TGA, in overt
2diabetes mother   was 17 times more than that of non diabetic women10.
The closure of ductus and decrease in pulmonary pressure were delayed in
babies of diabetic mother compared to a normal neonate. 11,12 Good
glycemic control had better outcome, lower occurrence of fetal heart
disease, but did not decrease the incidence of asymmetrical septal
hypertrophy.13 Diabetic cardiomyopathy  was self-limiting with no clinical
consequence and was a transient phenomenon that usually regressed within
first few months of life.1o Septal hypertrophy occurred even in mother with
good glycemic control,without relation to the type of diabetes.14 The
prevalence of septal hypertrophy in type 1 diabetes was more than that of
type 2 and GDM.15 The risk of congenital malformations was 3 to 4 times
higher than that of non-diabetic mother16. These babies were prone to be
larger, because of hyperglycemia & hyperinsulinemia2
32.STUDY JUSTIFICATION
Diabetes complicating pregnancy is increasing in incidence. Babies
born to these mothers have increased risk of complications including
intrauterine, intrapartum, perinatal . These babies are more susceptible for
various congenital anomalies such as cardiovascular, neural tube defects
and others.
Various studies have been done in this and showed the relationship
between maternal diabetes and fetal malformations / complications. This
study analyses the association between maternal type of diabetes, its
treatment and degree of glycemic status control with cardiac anomalies of
newborn.
43.AIM OF THE STUDY
To explore the spectrum of cardiovascular complication in infants of
diabetic mother and probable association between infant’s heart lesion.
- Type of maternal diabetes.
- Maternal treatment regimen
- Mother’s glycemic control
54. REVIEW OF LITERATURE
INFANT OF DIABETIC MOTHER
DIABETES OVERVIEW
Diabetes mellitus is one of the most common health problems in
pregnancy and it has negative outcomes to the infant born to them. Mostly
birth defects, most common defects involved cardiovascular and nervous
system-NTD [neural tube defect].
Diabetes mellitus: etiological classification
1. Type 1 diabetes mellitus (beta cell destruction)
a. immune mediated
b. idiopathic
2. Type 2 diabetes mellitus (insulin resistance)
3. Other specific types
A. Genetic defects of beta cell function
-maturity onset diabetes of young ( MODY)  defects in
chromosome 12,7,20,13,17,2. MODY 1 to 6
B. Genetic defects in insulin action -insulin resistance
C. Diseases of exocrine pancreas
Pancreatitis
6Trauma / pancreatectomy
Neoplasia
Cystic fibrosis
Calculus pancreatopathy
D. Endocrinopathies
Cushing syndrome
Acromegaly
Glucagonoma
Pheochromocytoma
Hyperthyroidism
E. Drug or chemical induced diabetes
Diabetes types – In pregnancy
1. Pregestational diabetes is the term used for women who
were diagnosed as diabetic before pregnancy.
a. Type I
b. Type II
2. Gestational diabetes is used to women who didn’t have
diabetes before pregnancy or became diabetic at some point
during pregnancy.
7Whatever may be the type of diabetes during  pregnancy there are some
adverse  effects to both mother and fetus health.17
Pregnancy  and diabetes
There is altered carbohydrate metabolism during pregnancy, it is the reason
for increased tendency of diabetes during pregnancy.
Pregnancy and its diabetogenic effects
1. Insulin resistance
 Placenta produces  human placental lactogen
 Cortisol, estriol, and progesterone increases during pregnancy
 Kidney and placenta destroys more insulin.
2. Lipolysis increased during pregnancy
Because utilization of glucose for fetus and mother energy based on
fat metabolism.
3. Changes in gluconeogenesis
The fetus preferentially utilizes alanine and other amino acids,
depriving themother of a major neogluconic source.
Factors that predict the pregnant women to become diabetic in future
are :
1 .Early diagnosis of gestational diabetes mellitius
82. Requiring insulin therapy
3. Preterm delivery
4. Large baby
5. Abnormal glucose tolerance test after 2months of childbirth
GDM is associated with increased risk of perinatal morbidities and
mortalities18
TYPES OF DIABETES MELLITUS
TYPE 1 DIABETES
Type I Diabetes  is an autoimmune disorder characterized by self
destruction of beta cells of pancreas, involving 5 to 10% of all peoples
with diabetes. In this, the body immune mechanism destroys beta cells
whose main function is secreting insulin.17The rate of destruction varies in
every individuals. 19
Type I features are complete absence of insulin, elevated blood
sugar level, catabolism of protein and fat. These people are susceptible to
develop DKA, a life threatening condition if not treated quickly. The main
action of insulin is to prevent lipolysis (i.e.) fat breakdown, to release free
fatty acids.
In type I diabetes, due to absence of insulin, free fatty acids are
released from the cells and the liver converts them into ketones causing
ketoacidosis. Decreased insulin production in pancreas necessitates the use
of exogenous insulin to prevent catabolic state and to achieve glucose
9control & prevent ketosis 19. Survival of these people is dependent on this
exogenous insulin17.There is genetic predisposition in some people.
Susceptible genes are HLA, insulin, PTPN22, ILR2a and CTLA4. TYPE
1diabetes is also called as insulin dependent Diabetes Mellitus or Juvenile
Diabetes.
TYPE II DIABETES MELLITUS.
This type accounts for 90 to 95% of all cases, characterized by a
heterogeneous condition. With an absolute absence of insulin associated
with the body cells failing to respond to available insulin properly. In this,
pancreas produces insulin, which is inadequate or not used well by the
cells.17The major abnormality is insulin resistance, when trying to
metabolize glucose & lipids.19
This is due to the unresponsive state of insulin receptors present in liver,fat
cells and muscle which result in hyperglycemia.17During the initial stages
of insulin resistance; pancreas produces high insulin in response to
hyperglycemia. This creates temporary hyperinsulinemia along with
hyperglycemia.19 In type II, there is an unbalanced insulin secretion &
increase in liver glucose. In type 2, people can have insulin levels of
high,to normal to low depending on many factors. The liver doesn’t
regulate the glucose release in response to changes in blood glucose. Type
2 diabetes is of gradual onset, many people being diagnosed only during
routine lab testings17.
10
Risk factors for type 2 Diabetes [according to International Diabetes
federation]
1. Family history of diabetes
2. Obesity
3. Physical inactivity
4. High blood pressure
5. Impaired glucose tolerance
6. Increased age
GESTATIONAL DIABETES MELLITUS
Third type of diabetes occurs in pregnant women, who had never
been diabetic before.GDM refers to any degree of glucose intolerance that
is identified during pregnancy.19Most commonly it affects the women who
are obese &with family history of diabetes.17In GDM, the developing
placenta impairs the maternal insulin during pregnancy. As pregnancy
advances the placenta produces more insulin blocking hormones thus
increasing maternal glucose & chance to have diabetes during
pregnancy.17GDM mothers are usually asymptomatic, but present with
excessive thirst& polyuria.
Risk factors:
a. Elderly mother
b. H/o GDM in previous pregnancy
c. Family h/o diabetes
11
d. Obesity prepregnancy BMI >30 21
e. Multifetal gestation
f. Recurrent UTI
g. Infertility treatment
h. H/o large babies
i. Unexplained neonatal death
j. Pre-eclampsia
k. Asian descent women17,18.
l. Birth of malformed infant before.21
m. Polyhydramnios  h/o
n. Maternal birth weight >4 kg21
o. PCOD
12
TABLE 1: WHITE CLASSIFICATION OF MATERNAL
DIABETES.20
GD Gestational diabetes: diabetes not known to be present before
pregnancy
GD diet Euglycemia maintained by diet only
GD insulin Diet alone insufficient required insulin
Class A Chemical diabetes; glucose intolerance before pregnancy; treated
by diet alone
Prediabetes; history of large baby or unexplained still birth after 28
weeks
Class B Insulin dependent , onset after 20 years of age
Duration < 10 years
Class C C1  onset @ 10 to 19 years
C2 duration of diabetes 10 to 19 years
Class D D1  onset before 10 years age
D2 duration of diabetes 20 years
D3 calcification of leg vessels
D4 hypertension
D5 benign retinopathy
Class F Nephropathy with proteinuria > 500mg/day
Class R Proliferative retinopathy / vitreal hemorrhage
Class RF Criteria for both R&F present
Class G Reproductive failure
Class H Atherosclerotic heart disease
Class T Prior to  renal transplantation
13
PATHOPHYSIOLOGY:
Maternal hyperglycemia leads to fetal hyperglycemia and fetal
hyperinsulinemia20 which results in fetal overgrowth: Pederson’s
hypothesis. Insulin requirements increases as pregnancy advances because
of hormones that are produced in placenta. As organogenesis occurs in
early trimester, hyperglycemia in early trimester has poor outcome.
1. Maternal hyperglcemia in early trimester that is periconceptional period
leads to fetal hyperglycemia will cause fetal embryopathic effects.
2. Fetal hyperglycemia leads to fetal hyperinsulinemia  and cause
a. Neonatal hypoglycaemia
b. Surfactant deficiency
c.Immature liver metabolism – NNH
3. Fetal hyperglycemia and hyperinsulinemia causes
a. Fetal macrosomia – difficult labour , birth asphyxia,
b. TTN
c. Cardiomyopathy
d. Polycythemia vascular events
14
DIAGNOSIS OF GDM
Gestational diabetes, generally, has few symptoms and it is most
commonly diagnosed by screening during pregnancy. Most women are
screened between 24 & 28 weeks of gestation as recommended by
American college of Obstetricians and Gynaecologist. ACOG – 2 Step
approach
Step 1: oral glucose challenge test21
Performed by giving 50grams of oral glucose irrespective of previous
meal,no fasting is required. Plasma glucose is measured after 1 hour.
Cutoff value< 140mg/dl.
If plasma glucose levels > 140mg/dl the screening is positive& requires
confirmative test.
STEP 2:  Oral glucose tolerance test21
After overnight fasting of 8hours, this test done with 100 grams of
glucose. Totally, 4 blood samples are taken.
a. 1st sample: FBS
b. 2nd sample: 1st hour PP sample
c. 3rd sample: 2nd hour PP sample
d. 4th sample: 3rd hour PP sample
15
Criteria for diagnosing gestational diabetes mellitus:
TABLE 2: CARPENTER AND COUSTAN CRITERIA22
If, out of these, any 2 values are abnormal, it is confirmed as a case of
gestational diabetes
SINGLE DIAGNOSTIC TEST 21
It is recommended by American Diabetes Association and International
Association of Diabetes and by WHO
1. Done only in females with high risk factor
2. Used for both screening & diagnostic purpose
3. Patients advised unrestricted diet for 72 hours followed by overnight
fasting and then 75gram of glucose is given.
4. Three samples taken
a. 1st – fasting sample
b. 2nd sample after 1 hour of 75gram glucose
c. 3rd sample after 2 hours of 75 gram glucose
Samples Blood glucose (mg/dl) Blood glucose ( mmol)
Fasting 95 5.3
1 hour 180 10.0
2 hour 155 8.6
3 hour 140 7.8
16
TABLE 3: SINGLE DIAGNOSTIC TEST - VALUES
Samples Blood glucose
(mg/dl)
Blood glucose
( mmol)
Fasting 92 5.1
1 hour 180 10.1
2 hour 153 8.5
Out of these 3 values if any one value is abnormal, then the patient is
considered as having gestational diabetes mellitus21
Women diagnosed with GDM have 60% lifetime risk of developing
overt type 2 diabetes20.
COMPLICATIONS OF MATERNAL DIABETES
MATERNAL  COMPLICATIONS:22
TYPE 1 &2:
a. Ketoacidosis
b.Macrovascular:nephropathy, hypertension
c. Microvascular:  retinopathy, neuropathy
d. Diabetic cardiomyopathy
e. Uteroplacental insufficiency
f. Polyhydramnios
17
Gestational diabetes mellitus:
1. Pregnancy induced hypertension
2. Preterm labour22
3. Still birth23
4. Antepartum hemorrhage
5. Premature rupture of membranes
6. Instrumental delivery
7. Pre-eclampsia
8. Caesarean section
9. Chorioamnionitis
10.Urinary tract infections.
FETAL COMPLICATIONS:
PREGESTATIONAL DIABETES:
1. Diabetic embryopathy20 –Periconceptional hyperglycemia and
poor glycemic control has been associated with a significantly increased
risk of congenital malformations. Risk increases with increasing maternal
HbA1c level in and around period of conception and 1st trimester. women
with >7.5%  level of HbA1c in 1st trimester  had a 9 fold increased risk of
congential malformations. Increased levels of glucose and increased
formation of ketone bodies found to be teratogenic in animal models.
Increased blood glucose leads to more free radical production which  will
18
cause membrane damage and mitochondrial dysfunction leads to
embryopathy.
2. Diabetic fetopathy20 - due to hyperglycemia in 2nd&3rd trimester.
These are any congenital malformations anticipated to be lethal  or require
surgical repair. There is no anomalies pathognomic for maternal diabetes.
But pregestational diabetes mellitus confers 26 fold  increased risk for
caudal regression syndrome.
3. Congenital malformations24: most common cardiac anomalies
comprise 40% to 50% of malformations encountered in IDM.
BIRTH DEFECTS:
When comparing pregestational diabetes & gestational diabetes more
birth defects occur in pregestational diabetes. Of these, neural tube defects
and cardiac defects are most common. The risk factor for congenital
malformations is hyperglycemia during early Trimester. Pregestational
diabetes is a risk for NTD& cardiac defects. When compared with non
diabetic mothers, the pre-existing diabetic mothers have 6 times high risk
to have babies with congential malformations.25 The birth defectsthat
occurs in newborn of diabetic mother with good glycemic control was
similar to that of non diabetic mother.26
The birth defects in order of prevalence20
a. Congenital heart disease
b. Central nervous  system defect
19
c. Urogenital defects
d. Limb defects
e.Orofacial defects
f. Sacral agenesis / caudal regression syndrome
There were many associations noted between pre-gestational
diabetes & congenital malformations of non cardiac defects –
hydrocephalus, anotia,microtia,anencephaly, craniorachischis, cleft lip,
renal agenesis, anorectal malformations , longitudinal limb abnormalities.
16 cardiac defects are identified. Of them 11 are associated with
pregestational diabetic mother. These includes TOF,
TGA,VSD,ASD,TAPVC,aortic stenosis, left & right ventricular outflow
tract obstruction. Complete AV canal defect and non-isolated AVseptal
defects are the leading cause of  death in congenital anomaly- related
deaths. More risk for malformation is obese women, pregestational
diabetes mother. Because of this, congenital heart defects incidence in
newborn of diabetic mother was 5 times more than that of general
population.27Maternal diabetes  modifies the gene expression involved in
heart development, which results from maternal hyperglycemia being
toxic to embryo.28
Most negative outcomes such as miscarriage& still births, congenital
anomalies are associated with pregnancy with poor glycemic control29.
Maternal hyperglycemia is an important factor affecting maternal well
20
being and neonatal morbidity and mortality.30 Pregestational diabetes with
good control and intense treatment had decreased malformations.
NEONATAL COMPLICATIONS: 20
1. Macrosomic babies or large babies :  maternal diabetes is
associated with abnormal growth patterns more commonly large for
gestational age . It is defined as birth weight greater than 90th
percentile for gestational age. This is due to maternal hyperglycemia
and fetal hyperinsulinemia as stated by Pederson hypothesis.fetal
hyperinsulinemia and increased insulin like growth factor results in
fetal over growth as evidenced by increased fat deposition and
visceral enlargement.
2. Shoulder dystocia31: leads to difficult vaginal delivery , birth
injuries and increased risk of perinatal asphyxia.
3. IUGR: Pregestational diabetes mellitus mother with
microvascular complications or associated chronic hypertension
have an increased risk of fetal growth restriction.
4. Respiratory distress:RDS is more common in IDM as compared
with newborn of non diabetic mother with same gestational age. It
may also involve late preterm IDMs. Respiratory distress in IDM is
due to delayed pulmonary maturation and surfactant production.
Insulin regulates fetal lung maturation, excess insulin levels have an
21
inhibitory effect on phosphatidyl glycerol synthesis and choline
incorporation in phosphatidyl choline.
5.Hypoglycemia32: it is one of the most common neonatal
morbidities in IDM. blood glucose <47mg/dl is defined as
hypoglycaemia. It is due to fetal hyperinsulinism. Symptoms of
hypoglycaemia may include tremor, jitteriness, irritability,lethary,
hyotonia. Convulsion, apnoea occurs in severe hypoglycaemia.
Recurrent or persistent hypoglycaemia may cause adverse
neurological outcome.
6. Hypocalcemia/ Hypomagnesimia: serum calcium <7mg/dl or
ionized calcium <4.4mg/dl defined as hypoglycaemia in newborns.
Hypomagnesemia defined as serum magnesium <1.5 mmg/dl.
Symptoms of hypocalcemia and hypomagnesemia are similar to
those of hypoglycaemia. Throughout the gestation , Calcium and
magnesium are transferred transplacentally. At delivery, these
supply terminated. In  IDM increased risk of hypocalcemia is due to
delayed transition from fetal to neonatal parathyroid action.
7. Polycythemia: venous hematocrit above 65% or haemoglobin >
20gm /dl. Polycythemic newborns have increased complications
resulting from hyperviscosity. These complications are ischemia and
infarction within kidneys – renal vein thrombosis, CNS- stroke.
Clinically polycythemic babies are plethoric, lethargic.
22
8. Hyperbilirubinemia : this is due to polycythemia  and ineffective
erythropoiesis with increased RBCs turnover, immaturity of
hepatobiliary system.
9. Renal vein thrombosis : due to polycythemia and increased
viscosity and sluggish circulation.
10. Small left colon syndrome
11. Poor feeding:
12. Premature baby
Management of diabetes in pregnancy.
Monitoring:
1. Testing for type 1 & 2 diabetes (first trimester)
a. By Measuring of glycosylated hemoglobin in the 1st trimester can
assess the risk for congenital anomalies by reflecting glucose
concentration in organogenesis period.
b. Accurate dating of pregnancy by USG
c. Ophthalmic examination is mandatory. Retinopathy is common in
type 1 &2. Mother with retinopathy needs periodic ophthalmic visit
& they are the candidate for laser photocoagulation.
d. Renal function: assessed by spot protein creatinine ratio or urine for
microalbuminuria, 24hr urine protein estimation , serum creatinine.
Baseline proteinuria impacts the diagnosis of pre-eclampsia later.
e. Thyroid function test: essential
23
f. Nuchal translucency and serum screening for aneuploidy.
2. Testingfor type 1 & 2 diabetes in 2nd trimester
a. Maternal serum screening for neural tube defects between 15 to
19 weeks . women with diabetes have 10 fold increased  risk for
NTD .
b. All mothers should undergo anomaly scan including detailed fetal
ECHO.20
3. Testing in  third trimester – type 1 &2 & GDM:
a. USG examination monthly
b. Fetal surveillance weekly or twice weekly
D. Fetal surveillance
Non stress test
Biophysical profile
Fetal heart rate monitoring.
Treatment of diabetes in 1st trimester
Maternal diabetes, through its adverse effects on maternal
metabolism, is the responsible factor for increase in malformations in the
offsprings33, so adequate control of maternal blood sugar is essential.
INSULIN TREATMENT:
The treatment choice for  overtly and pregestational diabetic
mother is insulin.34 Oral hypoglycemic agents are not effective in these
24
mothers. By regularizing diet and multiple insulin injections daily we can
achieve glycemic control.
TABLE 4: INSULIN TREATMENT
Insulin type Onset Peak Duration
SHORT ACTING
Lispro <15mins 0.5 -1.5 3-4
Glulisine <15mins 0.5 -1.5 3-4
Aspart <15mins o.5-1.5 3-4
Regular 30 to 60mins 2-3 4-6
LONG ACTING
Detemir 1to 4hr Minimal Upto 24
Glargine 1to 4hr Minimal Up to 24
NPH 1to 4hr 6 – 10 10 – 16
Monitoring: self monitoring of capillary blood glucose using glucometer is
essential for insulin titration.
TABLE 5: CBG GOALS
Samples Blood sugar (mg/dl)
Fasting <95
Premeal <100
1hr postprandial <140
2hr postprandial <120
Mean 100
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DIET: carbohydrate, protein, fat is adjusted according to individual
patient’s preference. Minimum carbohydrate diet of 175mg should be
provided as small to moderate meal size with snacks.
TREATMENT FOR ALL TYPE OF GLUCOSE TOLERANCE:
Strict diabetic controlachieved by diet modification,exercise,
medications.
Goals: Fasting <95mg/dl
Postprandial < 140mg/dl
By insulin therapy with more  perinatal safety.
Recently oral  hypoglycemic agents such as glyburide, metformin are as
effective as insulin therapy.
MANAGEMENT OF LABOR & DELIVERY
Iatrogenic preterm labour is common in diabetic mother20 because of
fetal complications such as non reassuring fetal heart tracing,
microvascular disease, uteroplacental insufficiency & pregnancy induced
hypertension. Antenatal steroids are necessary for fetal lung maturity.
Labour after 39 weeks doesn’t require Antenatal steroids for lung maturity.
Lung maturity is assessed by measuring amniotic fluid lecithin
spingomyelin ratio. Depending on fetal weight , maternal complications
and previous obstetric history route of delivery is decided. At an
emergency situation, L/S measurement is not necessary
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Management of IDM babies.
After the infant is born initial assessment is done by APGAR score.
Based on that, resuscitation required or not is decided. Airway is cleared of
secretion. Initial screening examination has to be done to rule out major
congenital anomalies. Basic supportive care, initial blood glucose
monitoring, and continuousevaluation of newborn should be given in
newborn nursery . Newborn should be evaluated for hemodynamic
stability, respiratory distress features, and cyanosis. Thorough clinical
examination should be done. Blood glucose monitoring @ 1,2,3,6,12,24,48
hours of life. Hematocrit, calcium blood levels should be checked.
All newborns should be thoroughly examined for cariac abnormalities (
ECG, CXR, ECHO).
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5.MATERIALS AND METHOD
STUDY DESIGN
Its is CROSS SECTIONAL DESCRIPTIVE STUDY
STUDY CENTRE
Our study was conducted in the sick new born ward, department of
paediatrics Tirunelveli medical college hospital, a tertiary care centre.
STUDY PERIOD
One year April 2017 to march 2018
STUDY POPULATION
Infants of diabetic  mothers born at Tirunelveli medical college
hospital, a tertiary care centre.
INCLUSION CRITERIA
All babies born to diabetic mothers both pre gestational and
gestational diabetic mother.
EXCLUSION CRITERIA
1. Babies born as still born
2. Babies born with features suggestive of chromosomal
abnormality
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3. Babies born to diabetic mothers with other co- morbidities like
hypothyroidism, hypertension, anemia complicating pregnancy, and
seizure disorder on AEDs.
4.  Babies born to diabetic mother with family history of heart disease.
5. Babies whose parents didn’t give consent to undergo study.
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6.METHODOLOGY
A prestructured proforma was used to obtain informations. The following
parameters at the time of admission were considered in the study
1. Maternal diabetes type,
2. Maternal treatment regimen,
3. Maternal glycemic status,
4. Antenatal ultra sonogram
5. Baby’s sex
6. Maturity,
7.  Birth weight,
8. Clinical manifestation murmur/ cyanosis {SaO2},
9. Chest x-ray finding,
10. ECG finding
11. ECHO finding
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All babies satisfying inclusion criteria were enrolled for study after
obtaining consent. At first, a data sheet was completed for each newborn
with the informations obtained.
All infants will undergo thorough physical examination with special
attention to cardiovascular system and following investigations done.
Oxygen saturation – by pulse oximetry low spo2 (95%), Electrocardiogram
(chamber enlargement changes in ECG),Chest X- ray (cardiomegaly),Echo
cardiogram (structural abnormality of heart- septal defect, shunt lesions.)
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STATISTICAL ANALYSIS
Data collected and recorded in the Proforma during the whole study
period were entered in Microsoft excel sheet and analysed to identify the
relation between maternal diabetes &cardiovascular abnormality in the
newborn born to them. The Software used in this study was SPSS software
version 21.0. Tests used were or comparing mean is T test and ANOVA.
For comparing the relation between groups, Chisquare and kruskal Wallis
test were used.
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7.OBSERVATION AND RESULTS
TOTAL CASES 100
TABLE 6: TYPES OF MATERNAL DIABETES
TYPE
NO OF
PATIENTS(N=100)
PERCENTAGE
(%)
PREGESTATIONAL 17 17
GESTATIONAL 83 83
Among 100 mothers, 17 had pre gestational diabetes and 83 had
gestational diabetes.
FIG 1: TYPES OF MATERNAL DIABETES
17%
83%
TYPE OF DM
PREGESTATIONAL
GESTATIONAL
33
TABLE 7: TYPES OF DIABETES AND ECHO ABNORMALITY
TYPE
TOTAL NO.
OF BABIES
EXAMINED
(N)
ECHO ABNORMALITY
PRESENT
(N) (%)
ABSENT
(N) (%)
PREGESTATIONAL 17 16 (94) 1 (6)
GESTATIONAL 83 12 (14) 71 (85.5)
CHI SQUARE TEST
P VALUE - 0.001
There was significant influence of the type of maternal diabetes present on
the outcome of these babies born to them. (i.e.)The ECHO abnormality
was significantly more common in pre gestational diabetes group.
FIG 2: TYPES OF DIABETES AND ECHO ABNORMALITY
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ECHO ABNORMALITY
DIABETIC TYPE VS CARDIAC
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TABLE 8: MATERNAL DIABETES AND TYPE OF ECHO
ABNORMALITY
TYPE
TOTAL NO.
ECHO
ABNORMALITY
(N)
TYPE OF ECHO ABNORMALITY
ACYANOTIC
(N)(%)
CYANOTIC
(N)(%)
PREGESTATIONAL 16 11 (68.7) 5 (31.3)
GESTATIONAL 12 12 (100) 0 (0)
CHI SQUARE TEST
P VALUE - 0.033 SIGNIFICANT
ECHO abnormalities were more common pre gestational diabetes
group, more of cyanotic heart disease.
FIG 3: MATERNAL DIABETES AND TYPE OF ECHO
ABNORMALITY
In our study, all  babies with cyanotic heart disease were born to mother
with pre gestational  diabetes.
68.70%
31.30%
100%
0%
0.00%
20.00%
40.00%
60.00%
80.00%
100.00%
120.00%
ACYANOTIC CYANOTIC
TYPE OF ABNORMALITY
PREGESTATIONAL GESTATIONAL
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TABLE 9: DISTRIBUTION OF TREATMENT REGIMEN OF
MOTHERS
TREATMENT REGIMEN NO OF PATIENTS(N) PERCENTAGE (%)
MEAL PLAN 66 66
OHA METFORMIN 21 21
INSULIN 13 13
Out OF 100 diabeticmothers, 66 were on meal plan, 21 were
on OHA metformin , 13 were  on insulin therapy.
FIG 4: DISTRIBUTION OF TREATMENT REGIMEN OF
MOTHERS
66%
21%
13%
TREATMENT REGIMEN
MEAL PLAN OHA INSULIN
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TABLE 10: ECHO ABNORMALITY AND MOTHERS
TREATMENT REGIMEN
TREATMENT
REGIMEN
TOTAL NO. OF
EXAMINED
(N=100)
ECHO ABNORMALITY
PRESENT
(N)(%)
ABSENT
(N) (%)
MEAL PLAN 66 8 (12) 58(88)
OHA 21 7 (33) 14(67)
INSULIN 13 13 (100) 0 (0)
KRUSKAL WALLIS TEST
P VALUE - 0.001
There was significant influence of maternal diabetes treatment
regimen in the outcome of babies born to them. Among 66 babies whose
mother was on meal plan, 8 had ECHO abnormality.  Of the 21 OHA
mothers, 7 had ECHO abnormality and of 13 INSULIN taking mothers, 13
had ECHO abnormality significantly.
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FIG 5: ECHO ABNORMALITY AND MOTHERS TREATMENT
REGIMEN
This representation showed that ECHO abnormality was found in
12% of babies born to mother on meal plan, 33% babies born to mother on
metformin , 100% of babies born to mother on insulin.
12%
33%
100%
88%
67%
0%
MEAL PLAN OHA INSULIN
PRESENT ABSENT
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TABLE 11: TYPE OF ECHO ABNORMALITY AND VARIOUS
MATERNAL TREATMENTREGIMENS
TREATMENT
REGIMEN
TOTAL NO OF
ECHO
ABNORMALITY
(N)
TYPE OF ECHO
ABNORMALITY
ACYANOTIC
(N)(%)
CYANOTIC
(N)(%)
MEAL PLAN 8 8 (100) 0(0)
OHA 7 7(100) 0 (0)
INSULIN 13 8 (61.53) 5 (38)
KRUSKAL WALLIS TEST
P VALUE - 0.030
SIGNIFICANT
Significant influence of maternal diabetes treatment regimen was
present on newborn heart disease. Mother on insulin treatment more
number of CHD.
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FIG 6: TYPE OF ECHO ABNORMALITY AND VARIOUS
MATERNAL TREATMENTREGIMENS
Of these, cyanotic heart disease was more common on
mothers taking insulin treatment, who had pre gestational diabetes
mellitus.
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TABLE 12: GLYCEMIC STATUS AMONG MOTHERS
GLYCEMIC CONTROL
HbA1c
NO OF PATIENTS
(N)
PERCENTAGE
(%)
WELL (<6) 83 83
POOR(>7) 7 7
UNKNOWN 10 10
Of 100 mothers, 83 had good glycemic control , 7 had poor
glycemic control,10 had their  glycemic status unknown.
FIG 7: GLYCEMIC STATUS AMONG MOTHERS
83%
7%
10%
CONTROL OF DIABETES
WELL
POOR
UNKNOWN
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TABLE 13:  MATERNAL GLYCEMIC STATUS AND ECHO
ABNORMALITIES AMONG THEIR IDM
GLYCAEMIC CONTROL
TOTAL NO.
BABIES OF
EXAMINED
(N)
ECHO ABNORMALITY
PRESENT
(N) (%)
ABSENT
(N) (%)
WELL (HbA1c <6) 83 18 (21.6) 65 (78.3)
POOR (HbA1c >6) 7 7 (100) 0 (0)
UNKNOWN 10 3(30) 7(70)
KRUSKAL WALLIS TEST
P VALUE - 0.001
Mother’s glycemic status had highly significant  influence over the
cardiovascular abnormalities in infants born to them.(< 0.001)
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Fig 8:MATERNAL GLYCEMIC STATUS AND ECHO
ABNORMALITIES AMONG THEIR IDM
This representation showed that 21% of babies  born to well
controlled mother and 100%  of babies born to poorly controlled mother
had ECHO abnormality .
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TABLE 14: MATERNAL GLYCEMIC STATUS & TYPE OF ECHO
NORMALITY
GLYCEMIC CONTROL
TOTAL NO OF
ECHO
ABNORMALITY
(N)
TYPE OF ECHO
ABNORMALITY
ACYANOTIC
(N) (%)
CYANOTIC
(N) (%)
WELL ( HbA1c<6) 18 18 (100) 0 (0)
POOR (HbA1c>6) 7 2(28.57) 5 (71.42)
UNKNOWN 3 3(100) 0(0)
KRUSKAL WALLIS TEST
P VALUE - 0.01
Babies born to mothers with poor glycemic control had significantly
more cyanotic heart disease than those born to mothers with good glycemic
control.
FIG 9: MATERNAL GLYCEMIC STATUS & TYPE OF ECHO
ABNORMALITY
18
2 3
0
5
0
W E L L POOR UNKNOWN
TYPE OF ECHO ABNORMALITY
ACYANOTIC CYANOTIC
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TABLE 15: AN – USG ABNORMALITIES AMONG IDM
AN- USG FINDING NO OF PATIENTS (N) PERCENTAGE (%)
PRESENT 6 6
ABSENT 94 94
Among 100 babies, 6 had abnormal findings in antenatal USG.
FIG 10: AN – USG ABNORMALITIES AMONG IDM
6%
94%
AN USG FINDING
PRESENT
ABSENT
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TABLE 16: AN – USG FINDINGS AND POSTNATAL ECHO
ABNORMALITY IN IDM
AN- USG FINDINGS
TOTAL NO.
BABIES
EXAMINED
(N)
ECHO ABNORMALITY
PRESENT
(N) (%)
ABSENT
(N) (%)
PRESENT 6 5 (83.33) 1 (16.6)
ABSENT 94 23 (24.46) 71 (75.53)
Out of 100IDM babies 6 had abnormal AN-USG findings, post natal
ECHO shows abnormality in 5 IDM.
Fig 11: AN – USG FINDINGS AND POSTNATAL ECHO
ABNORMALITY IN IDM
Among 6 babies with antenatal ultra-sonogram findings, 5 babies had
ECHO abnormality signifying the importance of antenatal ultra-sonogram.
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TABLE 17: GESTATIONAL AGE & ECHO ABNORMALITY
GESTATIONAL
AGE
TOTAL NO.
OF BABIES
EXAMINED
(N)
ECHO ABNORMALITY
PRESENT
(N)
PERCENTAGE
(%)
TERM 73 17 20
PRETERM 27 11 40
Among 100 babies 73 were term and 27 were preterm. Of 73 term babies
17 (20%) babies and 11 (40%) out of 27 preterm babies had ECHO
abnormality.
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TABLE 18: GENDER DISTRIBUTION AMONG IDM BABIES
GENDER
TOTAL NO.
OF BABIES
EXAMINED
(N)
ECHO ABNORMALITY
PRESENT (N) PERCENTAGE(%)
MALE 38 12 31
FEMALE 62 16 34
Among 100 babies, 38 were boys of which 12 had abnormal ECHO
finding and 62 were girl babies out of which 16 babies had abnormality in
ECHO. There was no difference in the incidence of ECHO abnormality
with respect to sex.
FIG 12: GENDER DISTRIBUTION AMONG IDM BABIES
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FIG 13: INTRAUTERINE GROWTH STATUS IN IDM
TABLE 19: INTRAUTERINE GROWTH STATUS & ECHO
ABNORMALITY IN IDM
BIRTH WEIGHT
TOTAL NO.
OF BABIES
EXAMINED
(N)
ECHO ABNORMALITY
PRESENT
(N)
PERCENTAGE
(%)
SGA 4 4 100
AGA 80 16 20
LGA 16 8 50
Among 100 babies studied 4 are SGA, 80 are AGA, 16 LGA. ECHO
abnormality present in all4 SGA, 16 (20%) AGA, 8(50%) LGA.
4%
16%
80%
BIRTH WEIGHT
SGA
LGA
AGA
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FIG 14: INTRAUTERINE GROWTH STATUS & ECHO
ABNORMALITY IN IDM
Babies’birth weight had significant influence on ECHO abnormality.
SGA babies showed 100% ECHO abnormality which reflected maternal
diabetes complications .next comes LGA with 50% ECHO abnormality
reflects maternal hyperglycemia & fetal hyperinsulinemia.
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TABLE 20: PRESENTATION OF DISEASE
PRESENTATION NO OF PATIENTS (N))
PERCENTAGE
(%)
SYMPTOMATIC 15 15
ASYMPTOMATIC 85 85
Out of 100 babies admitted in NICU, 15 were with symptoms and 85 were
asymptomatic.
FIG 15: PRESENTATION OF DISEASE
15%
85%
PRESENTATION
AT BIRTH
MORE THAN 24 HRS
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TABLE 21: PRESENTATION OF DISEASE & EXTENT OF ECHO
ABNORMALITY
PRESENTATION
TOTAL NO.
OF BABIES
EXAMINED
(N)
ECHO ABNORMALITY
PRESENT
(N) (%)
ABSENT
(N)(%)
SYMPTOMATIC 15 13 (86.6) 2(13.33)
ASYMPTOMATIC 85 15 (17.64) 70 (82.35)
Among symptomatic babies, 13(86.6%) had ECHO abnormality and 15
(17.64%) asymptomatic babies had ECHO abnormality.
FIG 16: PRESENTATION OF DISEASE & EXTENT OF ECHO
ABNORMALITY
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FIG 17:  MURMUR & IDM
Out of 100 newborns taken in the study, 14 newborn had murmur,
86 newborn had no murmur
14%
86%
MURMUR
PRESENT
ABSENT
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TABLE 22: MURMUR & ECHO ABNORMALITY IN IDM
MURMUR
TOTAL NO.OF
BABIES
EXAMINED(N)
ECHO ABNORMALITY
PRESENT(N) ABSENT(N)
BABIES WITH
MURMUR
14 11 3
BABIES  WITHOUT
MURMUR
86 17 69
11(78%) out of 14  newborn babies with murmur had ECHO
abnormality. 17 (21%) out of 86 newborn babies without murmur had
ECHO abnormality.
Fig 18: MURMUR & ECHO ABNORMALITY IN IDM
Echo abnormality was present in 21% babies presented without murmur, it
signifying  that every IDM babies should be screened for cardiovascular
anomalies.
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FIG 19: SPO2 LEVEL IN IDM
Out of 100 babies studied 5 babies presented with abnormal spo2
(spo2 <95%).
5%
95%
SPO2
ABNORMAL
NORMAL
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TABLE 23: SPO2 ABNORMALITY &  ECHO ABNORMALITY IN
IDM
SPO2
TOTAL NO.
OF
BABIES(N)
ECHO ABNORMALITY
PRESENT(N)(%) ABSENT(N)(%)
SPO2 < 95% 5 5 (100) 0 (0)
SPO2 > 95% 95 23(24.21) 72 (75.7)
All newborns with low spo2 had abnormal echo findings.
FIG 20: SPO2 ABNORMALITY &  ECHO ABNORMALITY IN IDM
All (100%) newborns with abnormal spo2 (<95%) had ECHO
abnormality signifying the importance of spo2 monitoring.
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FIG 21: ASSOCIATED ANOMALIES IN IDM
Out of 100 babies 3 babies had other congenital external anomalies such as
cleft lip, polydactyly.
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TABLE 24: ASSOCIATED ANOMALIES & ECHO
ABNORMALITY IN IDM
OTHER ANOMALIES
TOTAL NO.
OF BABIES
EXAMINED
(N)
ECHO ABNORMALITY
(N=28)
PRESENT
(%)
ABSENT
(N) (%)
PRESENT 3 3 (100) 0 (0)
ABSENT 97 25 (25.77) 72 (74.42)
Of 3 babies with other anomalies, all had ECHO  abnormality.
FIG 22: ASSOCIATED ANOMALIES & ECHO ABNORMALITY IN
IDM
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TABLE 25: CARDIOMEGALY IN IDM
CARDIOMEGALY NO. OF PATIENTS (N) PERCENTAGE (%)
PRESENT 9 9
ABSENT 91 91
Out of 100 babies studied 9 babies presented with cardiomegaly.(CXR
findings.)
FIG 23: CARDIOMEGALY IN IDM
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TABLE 26 : CARDIOMEGALY & ECHO ABNORMALITY IN IDM
CARDIOMEGALY
TOTAL NO. OF
BABIES WITH
CARDIOMEGALY
(N)
ECHO ABNORMALITY
PRESENT
(N) (%)
ABSENT
(N) (%)
PRESENT 9 9 (100) 0 (0)
ABSENT 91 19(20.8) 72 (79.12)
All 9 babies with cardiomegaly all had ECHO abnormality.
FIG 24: CARDIOMEGALY & ECHO ABNORMALITY IN IDM
Of the babies with cardiomegaly 100% had ECHO abnormality
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TABLE 27: ECG ABNORMALITY IN IDM
ECG ABNORMALITY NO OF PATIENTS (N)
PERCENTAGE
(%)
PRESENT 8 8
ABSENT 92 92
Out of 100 IDM examined 8 babies had abnormal ECG findings.
FIG 25: ECG ABNORMALITY IN IDM
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TABLE 28: ECG ABNORMALITY & ECHO ABNORMALITY IN
IDM
ECG ABNORMALITY
TOTAL
NO. OF
BABIES
(N)
ECHO ABNORMALITY
PRESENT
(N) (%)
ABSENT
(N)(%)
PRESENT 8 8 (100) 0 (0)
ABSENT 92 20 (21.73) 72 (78.2)
ECG abnormality was present in 8 babies all of which (100% ) were
associated with abnormal ECHO findings
FIG 26: ECG ABNORMALITY & ECHO ABNORMALITY IN IDM
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TABLE 29: DISTRIBUTION OF ECHOABNORMALITY IN IDM
ECHO ABNORMALITY
NO OF
PATIENTS(N)
PERCENTAGE (%)
PRESENT 28 28
ABSENT 72 72
Out of 100 babies examined , 28 (28%)babies had ECHO abnormality.72
babies had no ECHO abnormality
FIG 27: DISTRIBUTION OF  ECHO ABNORMALITY  IN IDM
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PRESENT ABSENT
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TABLE 30: DISTRIBUTION OF ACYANOTIC &   CYANOTIC
HEART DISEASE  IN IDM
TYPE OF CONGENITAL
HEART DISEASE
NO.OF
PATIENTS
(N=28)
PERCENTAGE
(%)
ACYANOTIC 23 82
CYANOTIC 5 18
Out of total 28 babies with ECHO abnormality, 23(82%) had acyanotic
heart disease,and 5(18%)  had cyanotic heart disease.
FIG 28: DISTRIBUTION OF ACYANOTIC&   CYANOTIC HEART
DISEASE IN IDM
82%
18%
TYPE OF ABNORMALITY
ACYANOTIC HD
CYANOTIC HD
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TABLE 31: DISTRIBUTION OF ACYANOTIC HEART DISEASE
IN IDM
ACYANOTIC HEART DISEASE
NO. OF
PATIENTS
(N=23)
PERCENTAGE
(%)
ATRIAL SEPTAL DEFECT 6 24
ASYMMETRICAL SEPTAL
HYPERTROPHY
8 32
OSTIUM PRIMUM ASD 1 4
PATENT DUCTUS ARTERIOSUS 3 12
PATENT FORAMEN OVALE 4 16
VENTRICULAR SEPTAL DEFECT 4 16
Of acyanotic heart diseases, septal hypertrophy had more incidence.
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Fig 29 : DISTRIBUTION OF  ACYANOTIC HEART DISEASE in
IDM
In acyanotic congenital heart disease , asymmetrical septal hypertrophy
was more common than others. Followed by ASD, PFO, VSD, PDA..
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TABLE 32 : DISTRIBUTION OF CYANOTIC HEART DISEASE IN
IDM
CYANOTIC HEART DISEASE
NO OF
PATIENTS(N=5) PERCENTAGE(%)
HYPOPLASTIC LEFT HEART SYNDROME 1 20
TRICUSPID ATRESIA 1 20
TRANSPOSITION OF GREAT VESSELS 2 40
TRUNCUS ARTERIOSUS 1 20
Of 18% cyanotic heart disease TGA had 40% incidence
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FIG 30: DISTRIBUTION OF CYANOTIC HEART DISEASE IN
IDM
Out of 5 cyanotic congenital heart disease babies , TGA 2(40%) was most
common. Followed by others.
20%
20%
40%
20%
CYANOTIC HEART DISEASE
HLHS
TA
TGA
TRUNCUS
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TABLE 33: RELATION BETWEEN TYPE OF MATERNAL
DIABETES AND HEART LESION
TYPE OF CARDIAC LESION
PREGESTATIONAL
(N)
GDM
(N)
P
VALUE
ATRIAL SEPTAL DEFECT 3 4 0.662
ASYMMETRICAL SEPTAL HYPERTROPHY 7 1 0.01
PATENT FORAMEN OVALE 0 4 0.05
VENTRICULAR SEPTAL DEFECT 2 2 0.823
PATENT DUCTUS ARTERIOSUS 1 2 0.791
HYPOPLASTIC LEFT HEART SYNDROME 1 0 0.887
TRANSPOSITION OF GREAT VESSELS 2 0 0.596
TRICUSPID ATRESIA 1 0 0.887
TRUNCUS ARTERIOSUS 1 0 0.887
On studying the relation between the type of heart lesion and maternal
diabetes, septal hypertrophy was more present in pregestational diabetic
mother1 (7 out of 17).
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TABLE 34: RELATION BETWEEN MATERNAL TREATMENT
REGIMEN AND HEART LESION
TYPE OF CARDIAC
LESION
MEAL
PLAN (N)
OHA
(N)
INSULIN
(N)
P
VALUE
ATRIAL SEPTAL DEFECT 4 1 2 0.729
ASYMMETRICAL
SEPTAL HYPERTROPHY
0 2 6 0.92
PATENT FORAMEN
OVALE
3 1 0 0.931
VENTRICULAR SEPTAL
DEFECT
0 2 2 0.887
PATENT DUCTUS
ARTERIOSUS
2 1 0 0.512
HYPOPLASTIC LEFT
HEART SYNDROME
0 0 1 0.05
TRANSPOSITION OF
GREAT VESSELS
0 0 2 0.173
TRICUSPID ATRESIA 0 0 1 0.05
TRUNCUS ARTERIOSUS 0 0 1 0.05
On comparing the relationship between maternal diabetes and treatment
plan , babies whose mother were on insulin had more number of echo
abnormality – cyanotic heart disease  HLHS (1), TA(1), TRUNCUS(1)
TGA(2). More asymmetrical septal hypertrophy ASD(2), VSD(2).
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TABLE 35: RELATION BETWEEN MATERNAL GLYCEMIC
CONTROL AND HEART LESION
TYPE OF CARDIAC
LESION
WELL
CONTROL
(N)
POOR
CONTROL
(N)
NOT
KNOWN
(N)
P
VALUE
ATRIAL SEPTAL DEFECT 4 1 1 0.862
ASYMMETRICAL SEPTAL
HYPERTROPHY 7 1 0 0.537
PATENT FORAMEN
OVALE 3 0 1 0.741
VENTRICULAR SEPTAL
DEFECT 3 1 0 0.596
PATENT DUCTUS
ARTERIOSUS 2 0 1 0.891
HYPOPLASTIC LEFT
HEART SYNDROME 0 1 0 0.718
TRANSPOSITION OF
GREAT VESSELS 0 2 0 0.152
TRICUSPID ATRESIA 0 1 0 0.718
TRUNCUS 0 1 0 0.718
Based on diabetic control, babies born to mothers with poor glycemic
control had significant ECHO abnormality with more incidence of cyanotic
heart disease. [TGA (2) TA (1) HLHS (1), truncus(1) ] than acyanotic
heart disease {ASH(1), ASD (1)}.
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8.DISCUSSION
In our study, 100 infants of diabetic mother were subjected to
echocardiogram, of this 28 (28%) babies had ECHO abnormality. Previous
similar study done on cardiovascular malformations in IDM reported by
meyer et al, showed incidence of 3.2 to 6.936and Avisa tabib et al showed
incidence of 8.8%35
Of the 100 IDM babies studied 17% mother was found to have pre-
gestational diabetes and 83% was found to have gestational diabetes. In
our study ECHO showed 94% of babies born to pre- gestational diabetes
had abnormality. Which is significant when compared to14%babies born
to gestational diabetes with significant P Value of 0.03.
Out of 28 babies who showed ECHO abnormality, 16 babies (57%)
were born to pre gestational diabetic mother and 12 babies (42%) were
born to gestational diabetic mother.
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TABLE 36: Comparison between Type of Maternal Diabetes and
Malformation In Related Studies
TYPE OF DIABETES Avisa tabib et al35 Present study
Pre gestational 68 17
Gestational 102 83
MalformationIn pregestational 7 16
MalformationIn gestational 8 12
Of the 16 babies born to pre gestational diabetic mother, 11 babies
(68.7) had ACHD and 5 babies (31.3) had CCHD.
Out of 100 IDM babies included in this study , 66% mothers were
on meal plan , 21% on OHA, 13% on insulin.
TABLE  37 : Comparison Between Maternal Treatment Regimen
And Malformation In Related Studies
TREATMENT REGIMEN Avisa tabib et al35 Present study
Meal plan 53 66
Insulin 117 13
Malformations  in meal plan
group
4 8
Malformations in insulin group 11 13
73
Previous study done by Avisa tabib et al35, showed mother who was
on insulin had increased risk of major cardiovascular malformation which
is comparable to our study. (P value 0.03)
In our study taken 100 IDM babies, 83% mothers had well controlled
glycemic status, 7% had poorly controlled, 10% had unknown glycemic
status. Of which echo abnormality was found to be more significant in
babies born to mother with poor controlled diabetes with preponderance of
cyanotic heart disease. It showed that mother’s glycemic status had
significant influence on CVS malformations compatible withthe
studiesdone by khan et al38 and mohan mekwana et al43. Babies of poorly
controlled glycemic status mother had poorer cardiac function.39,40
Of the 100 IDM study, 6 babies ( 6%) had AN- USG abnormality
and 94 babies normal AN – USG. On further evaluation using postnatal
echo 5 out of 6 AN – USG positivity cases showed abnormality, which is
similar to the previous studies done by avisa tabib et al35 and meyer et
al,36. Where   AN- USG screening with fetal ECHO had sensitivity of 90%
and specificity of 9935,36
Based on birth weight , 50% of LGA babies and all SGA babies had
significant cardiovascular abnormality in ECHO.
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In our study with 100 IDM babies, 14 babies presented with
murmur, 5 babies with low spo2 and 3 babies with external congenital
anomalies like polydactyl and cleft palate.
Of the 14 babies with ,11 babies (78%) had ECHO abnormality and
all babies with low spo2 and external congenital anomalies had ECHO
abnormality.
On investigation basis cardiomegaly  was present in 9% babies  and
all had ECHO abnormality more of septal hypertrophy.
Abnormal ECG was found in 8 babies out of  100 examined and all
had  ECHO findings consistent with more of septal hypertrophy and ASD ,
TGA.
In our study, of 100 IDM babies , 28 had echo abnormality, out of
this 23{82%} had acyanotic & 5 [18%] had cyanotic heart disease. In
acyanotic heart diseases  septal hypertrophy is more common than others
which was similar to that of previous studiesdone by avisa tabib et al and
zielinsky P et al .35,42
Parvin Akbariasbagh44 et al conducted a study on cardiovascular
malformations in infant of diabetic mother which showed significant
cardiovascular in infant of diabetic mother with p value of 0.018 which is
comparable to our study.(p= 0.01)
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In cyanotic heart disease, increased incidence was seen with
TGA(2)( 40%).HLHS 1, Truncus arteriosus 1, tricuspid atresia 1. These
types were more prevalent in diabetic pregnancy.10
On studying the relation between type of heart lesion and maternal
diabetes, septal hypertrophy was more in pregestational diabetic mother35
(7 out of 17) concordance to previous study done by avisa tabib et al,
followed by ASD (3), VSD(2), PDA(1).
Babies born to pre gestational diabetic mother showed more
cyanotic heart disease. {TGA(2), TA(1) Truncus(1) HLHS(1).} and babies
born to GDM mothers had more acyanotic heart disease.
On studying  the relationship between maternal diabetes and treatment
plan , babies whose mother were on  insulin had more number of echo
abnormality. Of which 5 babies had cyanotic heart diseaseTGA (2) (40%)
HLHS (1) (20%), TA (1) (20%), TRUNCUS ARTERIOSUS (1) (20%).
Babies whose mother was on meal plan also had cardiac abnormality
but of acyanotic heart disease with less significant ASD(4) PFO(3), PDA
(2). Mother with OHA treatment had echo abnormality of ASD(1),
VSD(2), PFO(1),PDA(1), ASH (2)
Based on diabetic control, babies born to mothers with poor glycemic
control, had significant ECHO abnormality with more incidence of
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cyanotic heart disease. TGA(2) TA(1) HLHS(1), truncus(1). Acyanotic
heart disease ASH(1), ASD (1).
Most of the babies born to well controlled mother had more of
acyanotic heart disease , with increased ASH(6) PFO(3), VSD(3), PDA(2),
ASD (5).
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9..LIMITATIONS.
1. HbA1c level could not be measured in 10 of diabetic mothers studied.
2. In our study HbA1c level was measured only once during the pregnancy
period randomly. So its effect on organogenesis specifically could not be
interpreted .
.
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10. CONCLUSION
1. In present study, acyanotic heart diseases were more common than
cyanotic heart disease in IDM.
2. Babies born to mother with pre gestational diabetic mellitus had
complex cyanotic heart disease than GDM mothers.
3. Babies whose mother had poor glycemic control had more incidence
of congenital heart disease.
4. Among acyanotic heart disease asymmetrical septal hypertrophy was
more common than other types.
5. Among cyanotic heart disease, Transposition of great arteries was
the most common cardiac anomaly in IDM babies.
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CASE PROFORMA
1. NAME :
2. AGE ON ADMISSION :
3. GENDER : FCH /MCH
4. MATERNAL DIABETES TYPE : PREGESTATIONAL /
GESTATIONAL
5. MATERNAL TREATMENT REGIMEN: MEAL PLAN/ OHA/INSULIN
6. MATERNAL GLYCEMIC CONTROL : WELL CONTROLLED /
POORLY CONTROLLED/
UNKNOWN
7. AN-USG : NORMAL / ABNORMAL
8. MATURITY : TERM/ PRETERM
9. BIRTH WEIGHT : SGA/AGA/LGA
10. PRESENTATION : SYMPTOMATIC /
ASYMPTOMATIC
11. MURMUR :  PRESENT / ABSENT
12. SPO2 ABNORMALITY : PRESENT / ABSENT
13. OTHER EXTERNAL ANOMALIES :  PRESENT / ABSENT
14. CARDIOMEGALY : PRESENT / ABSENT
15. ECG ABNORMALITY : PRESENT / ABSENT
16. ECHO ABNORMALITY : PRESENT / ABSENT
17. TYPE OF ECHO ABNORMALITY :  ACHD/CCHD
18. ACHD : ASD/VSD/ PDA/ PFO
ASYMMETRICAL SEPTAL
HYPERTROPHY
19. CCHD : TGA/ TA/ HLHS/ TRUNCUS
ATERIOSUS
20. OUTCOME : ALIVE / DEATH
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17 B/o Poomari Fch PT LGA A A A A A A A a
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19 B/o Muthumari Fch LPT LGA A A A A A A A a
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